Profile data is unavailable for this security.
About the company
Veeva Systems Inc. is a provider of cloud solutions for the global life sciences industry. It offers span cloud software, data, and business consulting and is designed to meet the needs of its customers and the strategic business functions from research and development (R&D) through commercialization. Its four product categories include Veeva Development Cloud, Veeva Quality Cloud, Veeva Commercial Cloud, and Veeva Data Cloud. Veeva Development Cloud includes application suites for the clinical, regulatory, and safety functions of life sciences companies, all built on its Veeva Vault platform. Veeva Quality Cloud unifies applications, processes, and partners across content management, training, quality management, assurance, and control lab solutions on the Veeva Vault platform. Veeva Commercial Cloud is a product category comprised of software and analytics solutions. Veeva Data Cloud is a data platform comprised of connected reference data, deep data, and transaction data.
- Revenue in USD (TTM)2.86bn
- Net income in USD780.66m
- Incorporated2007
- Employees7.29k
- LocationVeeva Systems Inc4280 Hacienda DrivePLEASANTON 94588United StatesUSA
- Phone+1 (925) 452-6500
- Fax+1 (925) 452-6504
- Websitehttps://www.veeva.com/medtech/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Steris PLC | 5.46bn | 610.12m | 23.49bn | 17.79k | 38.77 | 3.55 | 21.59 | 4.30 | 6.16 | 6.20 | 55.11 | 67.18 | 0.5148 | 4.87 | 5.32 | 306,938.50 | 5.77 | 5.04 | 6.36 | 5.51 | 44.01 | 43.75 | 11.20 | 10.69 | 1.39 | 12.76 | 0.236 | 37.51 | 6.24 | 12.49 | 10.64 | 8.40 | 11.52 | 8.99 |
| DexCom Inc | 4.15bn | 535.20m | 33.85bn | 10.30k | 66.20 | 14.93 | 44.52 | 8.16 | 1.30 | 1.30 | 10.11 | 5.78 | 0.6269 | 2.89 | 3.89 | 402,718.40 | 8.09 | 8.79 | 12.44 | 11.75 | 60.72 | 64.97 | 12.90 | 14.90 | 1.32 | -- | 0.5246 | 0.00 | 11.34 | 22.27 | 6.41 | 41.63 | 14.79 | -- |
| Agilent Technologies Inc | 6.63bn | 1.17bn | 33.85bn | 18.00k | 29.33 | 5.51 | 23.46 | 5.11 | 4.06 | 4.06 | 23.09 | 21.61 | 0.576 | 3.08 | 5.07 | 370,279.30 | 10.13 | 10.93 | 12.25 | 13.09 | 53.77 | 53.35 | 17.59 | 17.93 | 1.60 | 24.95 | 0.3629 | 21.83 | -4.73 | 4.75 | 3.95 | 3.77 | 19.36 | 7.80 |
| GE HealthCare Technologies Inc | 19.80bn | 2.18bn | 34.06bn | 53.00k | 15.64 | 3.71 | 12.08 | 1.72 | 4.76 | 4.76 | 43.13 | 20.07 | 0.6018 | 5.54 | 4.51 | 373,547.20 | 6.84 | -- | 9.67 | -- | 41.99 | 40.35 | 11.37 | 10.78 | 0.7601 | 8.18 | 0.483 | 1.19 | 0.6138 | 3.41 | 43.48 | 3.82 | 3.91 | -- |
| Resmed Inc | 5.02bn | 1.31bn | 37.41bn | 9.98k | 28.65 | 6.75 | 24.60 | 7.45 | 8.91 | 8.91 | 34.05 | 37.83 | 0.6983 | 2.45 | 5.65 | 503,159.20 | 18.26 | 14.24 | 20.73 | 16.53 | 58.76 | 56.85 | 26.15 | 20.35 | 2.49 | 58.86 | 0.1082 | 32.62 | 10.95 | 12.44 | 13.75 | 19.98 | 8.23 | 5.34 |
| IDEXX Laboratories Inc | 3.93bn | 894.97m | 42.73bn | 11.00k | 49.10 | 29.63 | 41.52 | 10.87 | 10.82 | 10.82 | 47.53 | 17.93 | 1.20 | 3.87 | 6.81 | 357,439.60 | 27.26 | 28.11 | 40.01 | 42.15 | 61.28 | 59.56 | 22.76 | 22.19 | 0.8111 | 53.37 | 0.3937 | 0.00 | 6.46 | 10.12 | 5.07 | 15.73 | -3.35 | -- |
| Edwards Lifesciences Corp | 5.54bn | 1.44bn | 45.88bn | 15.80k | 32.27 | 4.53 | 29.07 | 8.28 | 2.42 | 7.00 | 9.31 | 17.28 | 0.4867 | 0.984 | 7.45 | 350,557.00 | 12.63 | 14.52 | 14.28 | 16.61 | 79.38 | 79.01 | 25.95 | 25.54 | 3.66 | -- | 0.0554 | 0.00 | 8.57 | 4.58 | 14.55 | 5.94 | 0.2857 | -- |
| Veeva Systems Inc | 2.86bn | 780.66m | 46.31bn | 7.29k | 60.12 | 7.44 | 56.38 | 16.22 | 4.71 | 4.71 | 17.25 | 38.11 | 0.4093 | -- | 6.06 | 391,622.10 | 11.19 | 11.33 | 13.85 | 14.35 | 75.50 | 72.60 | 27.34 | 23.96 | -- | -- | 0.00 | 0.00 | 16.20 | 19.99 | 35.84 | 18.85 | 36.56 | -- |
| Becton Dickinson and Co | 20.87bn | 1.50bn | 48.97bn | 74.00k | 33.09 | 1.94 | 12.66 | 2.35 | 5.16 | 5.16 | 71.96 | 88.07 | 0.3842 | 3.32 | 7.47 | 281,986.50 | 2.76 | 2.55 | 3.20 | 2.92 | 44.68 | 45.30 | 7.18 | 7.29 | 0.6427 | 7.18 | 0.4329 | 76.93 | 4.16 | 3.14 | 15.99 | 10.56 | -5.40 | 4.29 |
| Cencora Inc | 310.23bn | 1.69bn | 58.03bn | 42.00k | 34.75 | 57.29 | 20.64 | 0.1871 | 8.62 | 8.62 | 1,574.00 | 5.23 | 4.59 | 16.40 | 12.70 | 7,386,481.00 | 2.53 | 1.12 | 10.78 | 4.84 | 3.29 | 3.24 | 0.55 | 0.2556 | 0.517 | 17.30 | 0.8694 | 62.15 | 12.12 | 10.36 | -13.53 | 13.02 | 9.45 | 4.98 |
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Mar 2025 | 14.37m | 8.85% |
| BlackRock Fund Advisorsas of 31 Mar 2025 | 6.94m | 4.28% |
| AllianceBernstein LPas of 31 Mar 2025 | 5.50m | 3.39% |
| T. Rowe Price Investment Management, Inc.as of 31 Mar 2025 | 5.20m | 3.21% |
| Fidelity Management & Research Co. LLCas of 31 Mar 2025 | 5.15m | 3.17% |
| T. Rowe Price Associates, Inc. (IM)as of 31 Mar 2025 | 3.87m | 2.39% |
| SSgA Funds Management, Inc.as of 31 Mar 2025 | 3.46m | 2.13% |
| Principal Global Investors LLCas of 31 Mar 2025 | 3.15m | 1.94% |
| Geode Capital Management LLCas of 31 Mar 2025 | 2.98m | 1.84% |
| Massachusetts Financial Services Co.as of 31 Mar 2025 | 2.73m | 1.68% |
